[go: up one dir, main page]

CA2763647A1 - Procedes d'utilisation de l'huile de krill a des fins de traitement des facteurs de risque associes aux affections metaboliques, cardiovasculaires et inflammatoires - Google Patents

Procedes d'utilisation de l'huile de krill a des fins de traitement des facteurs de risque associes aux affections metaboliques, cardiovasculaires et inflammatoires Download PDF

Info

Publication number
CA2763647A1
CA2763647A1 CA2763647A CA2763647A CA2763647A1 CA 2763647 A1 CA2763647 A1 CA 2763647A1 CA 2763647 A CA2763647 A CA 2763647A CA 2763647 A CA2763647 A CA 2763647A CA 2763647 A1 CA2763647 A1 CA 2763647A1
Authority
CA
Canada
Prior art keywords
krill oil
subject
krill
liver
levels
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2763647A
Other languages
English (en)
Inventor
Inge Bruheim
Snorre Tilseth
Jeffrey Cohn
Mikko Griinari
Sebastiano Banni
Daniele Mancinelli
Nils Hoem
Hogne Vik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qrill Co AS
Original Assignee
Aker Biomarine ASA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aker Biomarine ASA filed Critical Aker Biomarine ASA
Publication of CA2763647A1 publication Critical patent/CA2763647A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cardiology (AREA)
  • Insects & Arthropods (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2763647A 2009-05-28 2010-05-28 Procedes d'utilisation de l'huile de krill a des fins de traitement des facteurs de risque associes aux affections metaboliques, cardiovasculaires et inflammatoires Abandoned CA2763647A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18174309P 2009-05-28 2009-05-28
US61/181,743 2009-05-28
PCT/IB2010/001478 WO2010136900A2 (fr) 2009-05-28 2010-05-28 Procédés d'utilisation de l'huile de krill à des fins de traitement des facteurs de risque associés aux affections métaboliques, cardiovasculaires et inflammatoires

Publications (1)

Publication Number Publication Date
CA2763647A1 true CA2763647A1 (fr) 2010-12-02

Family

ID=43034639

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2763647A Abandoned CA2763647A1 (fr) 2009-05-28 2010-05-28 Procedes d'utilisation de l'huile de krill a des fins de traitement des facteurs de risque associes aux affections metaboliques, cardiovasculaires et inflammatoires

Country Status (3)

Country Link
EP (1) EP2435055A2 (fr)
CA (1) CA2763647A1 (fr)
WO (1) WO2010136900A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2779334C (fr) 2009-10-30 2017-05-30 Tharos Ltd. Procede sans solvant pour l'obtention d'huile de krill enrichie en phospholipides et d'huile de krill enrichie en lipides neutres
US8691297B2 (en) 2010-09-01 2014-04-08 Nippon Suisan Kaisha, Ltd. Alcoholic injury mitigating agent
CN103327982A (zh) * 2011-02-01 2013-09-25 日本水产株式会社 性功能改善剂
WO2012103685A1 (fr) * 2011-02-01 2012-08-09 Nippon Suisan Kaisha, Ltd. Agent d'amélioration de la fonction sexuelle
US8846604B2 (en) 2011-09-02 2014-09-30 Artic Nutrition AS Lipid compositions with high DHA content
WO2013160914A1 (fr) * 2012-04-25 2013-10-31 Ezhil Arasan Ramanan Nouvelle composition synergique comprenant un caroténoïde, un serm et un dérivé d'acide aminé
FR3015860B1 (fr) * 2013-12-30 2019-08-16 Pronokal Health Group, Sociedad Limitada Composition alimentaire de regime pour diminuer l'inflammation de bas grade a court et long terme comprenant de l'acide docosahexaenoique
WO2016055860A1 (fr) * 2014-10-10 2016-04-14 Enzymotec Ltd. Préparations de lécithine marine à résistance accrue à l'oxydation
CA2971786A1 (fr) 2015-03-31 2016-10-06 Fresenius Kabi Deutschland Gmbh Emulsions pour administration parenterale
US10328105B2 (en) 2015-05-27 2019-06-25 Rimfrost Technologies As Flowable concentrated phospholipid krill oil composition
CN107987948A (zh) * 2017-06-25 2018-05-04 青岛康境海洋生物科技有限公司 一种调节血脂的南极磷虾油制剂
WO2020055913A1 (fr) * 2018-09-10 2020-03-19 Cardax, Inc. Procédés de réduction de la protéine c réactive et/ou de traitement d'une maladie cardiovasculaire
WO2021138742A1 (fr) * 2020-01-10 2021-07-15 Acasti Pharma Inc. Composition favorisant des médiateurs pro-résolution

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2909508B2 (ja) 1989-02-14 1999-06-23 マルハ株式会社 オキアミリン脂質の分取方法
CA2251265A1 (fr) 1998-10-21 2000-04-21 Universite De Sherbrooke Procede d'extraction des lipides de tissus d'animaux aquatiques produisant un residu deshydrate
CN1516592A (zh) 2001-06-18 2004-07-28 �����Ǽ���&������Դ���޹�˾ 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
AU2002322233C1 (en) 2001-07-27 2014-02-13 Aker Biomarine Antarctic As Natural marine source phospholipids comprising flavonoids, polyunsaturated fatty acids and their applications
KR20060008155A (ko) 2004-07-23 2006-01-26 최희성 퇴행성 관절염 억제용 글루코사민과 크릴유 배합물
US7666447B2 (en) 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
WO2007080515A1 (fr) 2006-01-13 2007-07-19 Aker Biomarine Asa Extrait de krill prevenant la thrombose
US20080166419A1 (en) * 2007-01-04 2008-07-10 Sones Scott F Krill oil compositions
WO2008117062A1 (fr) * 2007-03-28 2008-10-02 Aker Biomarine Asa Compositions d'huile de krill biologiquement efficaces

Also Published As

Publication number Publication date
EP2435055A2 (fr) 2012-04-04
WO2010136900A3 (fr) 2011-06-16
WO2010136900A2 (fr) 2010-12-02

Similar Documents

Publication Publication Date Title
US9730966B2 (en) Method of reducing appetite in a human subject comprising administering krill oil composition
CA2763647A1 (fr) Procedes d'utilisation de l'huile de krill a des fins de traitement des facteurs de risque associes aux affections metaboliques, cardiovasculaires et inflammatoires
US20240189366A1 (en) Bioeffective krill oil compositions
AU2013319911B2 (en) Omega-3 phospholipid supplements for females
AU2017201340B2 (en) Bio effective krill oil compositions
AU2013227998C1 (en) Bioeffective krill oil compositions

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20161208